Impact of Polyvascular Disease on Long-Term Prognosis of Patients with Acute Coronary Syndrome—A Retrospective Cohort Study in Italy
<b>Background</b>: Atherothrombosis is a systemic disease that may affect one or more than one vascular bed. Data on the impact of polyvascular disease (PVD) on the long-term prognosis of patients with coronary artery disease (CAD) are still scarce. Aim: To assess the prevalence of symptomatic PVD in a cohort of patients with a new episode of acute coronary syndrome (ACS) and to investigate the impact of multiple vascular beds involvement on long-term outcomes. <b>Methods</b>: We analysed a nationwide, comprehensive administrative database of consecutive patients aged ≥ 40 years admitted for a new episode of ACS in Italy in 2017-2018. Patients with ACS were stratified according to the presence of peripheral artery disease (PAD) only; cerebrovascular disease (CeVD) only; PAD+CeVD; or neither (no PAD/noCeVD, i.e., ACS only). A multivariate Cox proportional hazards model was used to assess the impact of PAD only; CeVD only and PAD+CeVD on 5-year MACCE. <b>Results</b>: A total of 342,052 patients hospitalised with ACS were identified. Among them, 24,727 (7.2%) were patients with PAD only, 16,887 (4.9%) with CeVD only, and 5810 (1.7%) with PAD+CeVD. After adjusting for age, sex, and comorbidities, the hazard ratio (HR) for 5-year MACCE was 1.37 (95% CI: 1.35-1.40), 1.36 (95% CI: 1.33-1.39), and 1.45 (95% CI: 1.40-1.50) in patients with PAD only, CeVD only, and PAD+CeVD, respectively, compared with patients with ACS only. <b>Conclusions</b>: In patients with ACS, the involvement of a second vascular bed increases the risk of long-term outcomes; the simultaneous involvement of three vascular beds further increases the risk of long-term outcomes.
Authors
- Gabriella Badoni (ORCID: https://orcid.org/0000-0003-0562-4923)
- Francesco Fattirolli (ORCID: https://orcid.org/0000-0002-1345-0284)
- Paola D’Errigo (ORCID: https://orcid.org/0000-0002-3174-4278)
- Giovanni Baglìo (ORCID: https://orcid.org/0000-0001-8313-794X)
- Marco Ambrosetti (ORCID: https://orcid.org/0000-0002-9878-4565)
- Pompilio Faggiano (ORCID: https://orcid.org/0000-0002-7997-6908)
- Gian Francesco Mureddu (ORCID: https://orcid.org/0000-0002-3340-7865)
- Stefano Rosato (ORCID: https://orcid.org/0000-0002-6690-5537)
- Paola Ciccarelli
Institutions
- Istituto Superiore di Sanità (IT)
- Azienda Ospedaliera San Giovanni Addolorata (IT)
- Fondazione Poliambulanza Istituto Ospedaliero (IT)
- University of Florence (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3390/jcm14124158
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00